|Articles|July 27, 2006
Correction
Last month's edition of The BioPharm Bulletin contained an error in the article, "Promise and Challenges of Biotech Vaccines."
Advertisement
Last month’s edition of TheBioPharm Bulletin contained an error in the article, “Promise and Challenges of Biotech Vaccines.” The 6th line from the end of the article should have read, “Deshmukh cited the example of the Prevnar vaccine, which requires a total of 14 or 15 separate processes, to make seven different polysaccharides and a carrier protein, and then seven conjugates.”
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
